Mari Anne Snow

Mari Anne Snow is the CEO and co-founder of Eascra Biotech, where she leads commercialization of the company’s DNA-inspired nanomaterial platform to enable next-generation therapeutic delivery and regenerative medicine. She has successfully secured millions in non-dilutive funding from NASA, NSF, the ISS National Lab, and the U.S. Air Force to advance Eascra’s Earth- and space-based manufacturing strategy. With a background spanning biotechnology, executive leadership, and strategic growth, she has built global partnerships across academia, industry, and government to accelerate clinical translation. Mari Anne is a recognized advocate for the future of in-space biomanufacturing and is committed to bringing transformative therapies to patients with unmet medical needs.